The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the phase Ib portion of a phase I/II trial of the indoleamine 2,3-dioxygenase pathway (IDO) inhibitor indoximod plus gemcitabine/nab-paclitaxel for the treatment of metastatic pancreatic cancer.
 
Nathan Bahary
No Relationships to Disclose
 
Ignacio Garrido-Laguna
No Relationships to Disclose
 
Andrea Wang-Gillam
No Relationships to Disclose
 
Asha Nyak-Kapoor
No Relationships to Disclose
 
Eugene Kennedy
No Relationships to Disclose
 
Nicholas N. Vahanian
No Relationships to Disclose
 
Charles J. Link
No Relationships to Disclose